Company / Depreciation & Amortization
CAPRICOR THERAPEUTICS, INC. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$1.9M
FY2025
5-year range
$245.7K / $1.9M
FY2021-FY2025
Trend
+32.5%
vs FY2024
Sector context
#108 of 177
Health Care
What the data says
At $2M, CAPRICOR THERAPEUTICS, INC.'s depreciation & amortization ranks #70 of 177 in the Health Care sector. Depreciation & Amortization has increased for 5 consecutive years, from $143,890 in FY2020 to $2M in FY2025.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of +67.4%.
Increased from $1M to $2M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +52.5%
- 5-Year CAGR
- +67.4%
- 10-Year CAGR
- -
Sector benchmark
#70 of 177 in Health CareTop 39% of 177This company $1.9M Sector average $204.7M
▼
-99.1% below sector average
Key checks
Key Insights
- CAPRICOR THERAPEUTICS, INC.'s depreciation & amortization has grown for 5 consecutive years.
- 5-year CAGR of +67.4%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 32.5% year-over-year.
- Ranks #108 out of 177 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.9M | +32.5% |
| FY2024 | $1.4M | +33.3% |
| FY2023 | $1.1M | +100.5% |
| FY2022 | $533.1K | +117.0% |
| FY2021 | $245.7K | +70.8% |
| FY2020 | $143.9K | -8.7% |
| FY2019 | $157.7K | +0.0% |
| FY2018 | $157.7K | +9.3% |
| FY2017 | $144.2K | +14.7% |
| FY2016 | $125.7K | +13.4% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026